1 comments

  • bhouston 6 hours ago

    TL;DR summary:

    The drug cut inflammation markers (IL-6, CRP) as intended but didn't reduce cardiovascular events or deaths versus placebo. This undermines the "inflammation causes atherosclerosis" thesis.